Semantic Scholar uses AI to extract papers important to this topic.
Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated… Expand BACKGROUND
Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We… Expand BACKGROUND
The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction… Expand CONTEXT
Gene expression analysis has identified several breast cancer subtypes, including basal-like, human epidermal growth… Expand Chronic lymphocytic leukemia (CLL) is the most common human leukemia and is characterized by predominantly nondividing malignant… Expand The clinical use of anthracyclines like doxorubicin and daunorubicin can be viewed as a sort of double-edged sword. On the one… Expand Purpose: Expression profiling studies classified breast carcinomas into estrogen receptor (ER)+/luminal, normal breast-like, HER2… Expand PURPOSE
To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node… Expand In December 1997, the National Cancer Institute sponsored "The International Workshop on Microsatellite Instability and RER… Expand One reason for the poor immunogenicity of many tumors may be that they cannot provide signals for CD28-mediated costimulation… Expand